AI Is Already in the Room - The Question Is Whether You’re Using It
Written By Josh Lampropoulos
I’ll be honest — a year ago, I was skeptical. Not about whether AI was real or capable, but about whether it was actually relevant to the work I do every day in medical equipment financing. It felt like something for tech companies and Silicon Valley, not for healthcare sales reps and provider relationships.
I was wrong. And the speed at which that became clear surprised me.
Today, AI is showing up in virtually every corner of healthcare — from how providers diagnose and treat patients, to how sales teams prospect and communicate, and even to how finance teams evaluate equipment investments. It’s not a future thing. It’s a right now thing. And the organizations that treat it that way are already pulling ahead.
What’s Actually Happening in Healthcare
When most people hear “AI in healthcare,” they picture robots performing surgery. The reality is both less dramatic and more immediately impactful.
AI is being used today to flag early warning signs in patient vitals before a crisis occurs. It’s helping radiologists catch findings they might have missed on a long shift. It’s streamlining prior authorizations that used to take days. It’s identifying which patients are at high risk for readmission so care teams can intervene earlier.
None of that is science fiction. It’s happening in hospitals and specialty practices right now — and it’s changing what “standard of care” looks like going forward.
For care providers, the practical question isn’t whether AI matters, it’s how to access it thoughtfully, implement it effectively, and afford it without disrupting operations.
The Business Case Is Real
From a business perspective, AI-driven tools in healthcare are producing measurable results: shorter patient wait times, reduced administrative burden on staff, fewer billing errors, and better outcomes data that supports stronger reimbursement arguments.
That last one is worth pausing on. In a reimbursement environment that increasingly rewards outcomes over volume, having better data — and tools that help generate it — is a genuine competitive advantage. Practices that can demonstrate superior patient outcomes have a stronger case for premium procedures, stronger referral relationships, and more loyal patients.
The challenge, of course, is that AI-integrated equipment and software aren’t cheap. And for many providers, especially independent practices and smaller health systems, the upfront cost feels like the barrier. That’s where financing enters the conversation — but more on that in a moment.
What It Means for How We Work
On the business side of healthcare — the side I live in — AI is also reshaping how teams operate. I use it regularly now to draft communications, research prospect companies, organize my thinking before a strategic account call, and move faster on tasks that used to take much longer.
That’s not about replacing the relationship or the judgment. Those still matter enormously in this business. But it does mean that the teams who figure out how to use AI as a productivity tool — not a crutch, but a tool — are going to have a real edge in how much they can accomplish and how well they can serve their partners.
I think that’s true whether you’re a sales rep, a practice administrator, a clinician, or a CFO. AI is a force multiplier for people who know what they’re doing. The goal is to be one of those people.
The Access Question
Here’s where I’ll bring it back to what we do at Med One, because I think it’s genuinely relevant:
A lot of the most impactful AI-integrated medical equipment — advanced imaging systems, surgical robotics, diagnostic platforms with machine learning built in — carries a significant price tag. For providers who want to stay current without depleting cash reserves or waiting for a capital budget cycle, financing is often what makes adoption possible.
Structured correctly, a financing arrangement can let a practice access a $150,000 AI-powered diagnostic platform today, align payments with the revenue that platform generates, and preserve capital for the operational investments that can’t be financed. That’s not a workaround — that’s a sound financial strategy.
The providers who will lead in the AI era won’t necessarily be the largest or the best-funded. They’ll be the ones who are intentional about how they adopt new technology and smart about how they fund it.
Where This Is All Headed
I’m not here to predict exactly what AI will look like in healthcare five years from now. Honestly, the pace of change makes that a fool’s errand. What I’m confident about is this: the organizations that approach AI with curiosity rather than skepticism, and with a clear plan rather than reactive urgency, are going to be in the best position — for their patients, their staff, and their bottom line.
That applies to care providers deciding which technologies to invest in and to all of us at Med One, too.
The room has changed. The question is just whether we’re keeping up with it.